Don't miss it on AMBS - the most undervalued micro-cap biotech in the market. Currently trading under a nickle.
Read the recent Yahoo news. License agreement with Becton Dickinson would move the share price above .50.
8,390 followers on Twitter: $AMBS@AmarantusBio
Buya few shares and hold them for three months.
1,000% upside short term.
Read today's news on Yahoo.
MCET is a better wager.